Clinical trial · Observational
EUS-guided FNA in the Study of the Adrenal Gland
EUS-guided FNA in the Study of the Adrenal Gland: National Retrospective Multicenter Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To analyze the diagnostic performance, safety, impact on clinical management, predictors of malignancy and cyto-pathological correlation of the EUS-FNA with AG. National multicenter retrospective study. Mailing-SEED partners. Participation: 17 Spanish centers. Inclusion period: April / 2003 to April / 2016 Inclusion criteria: All AG (Left / Right) punctured by EUS. A review of 205 EUS-FNA of AG in 200 patients is included.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adrenal Gland Disease | — | UNRESOLVED | — |
| Adrenal Tumor | Adrenal Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endoscopic Ultrasound-Guided FNA | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Diagnostic accuracy
- timeFrame
- retrospective analysis form 2003 to 2016
Secondary outcomes (2)
- measure
- number of adverse events related to the procedure
- timeFrame
- retrospective analysis, last 10 years
- measure
- Predictors of malignancy
- timeFrame
- retrospective analysis, last 10 years
- description
- Predictors of malignancy and cyto-pathological correlation of the EUS-FNA with adrenal gland
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All adrenal gland (Left / Right) punctured by endoscopic ultrasound
References
Publications (0)
Data not yet available